TWST250117C80000
- 0.70
- 0.000.00%
Twist Bioscience Newsroom
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Wolfe Research Initiates Twist Bioscience(TWST.US) With Buy Rating, Announces Target Price $60
Twist Bioscience Initiated With an Outperform at Wolfe Research
Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers
Express News | Twist Bioscience Corp : Guggenheim Raises Target Price to $58 From $53
We're Not Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Twist Bioscience Named a Best Idea for 2025 at TD Cowen
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $58
Express News | Twist Bioscience Shares Are Trading Higher After Leerink Partners Maintained Its Hold Rating on the Stock
Cautious Outlook for Twist Bioscience Amid Regulatory Changes and Competitive Pressures
Express News | Scorpion Capital- Remain Short on Twist Bioscience
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations
Twist Bioscience Price Target Lowered to $52 From $55 at Barclays
Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $52
Twist Bioscience Price Target Raised to $54.00/Share From $50.00 by Scotiabank